Want to see AU:ENP full AI Analyst Report?

Tryptamine Therapeutics (ENP) Revenue

19 Followers

Tryptamine Therapeutics Revenue

Tryptamine Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Jun 30, 2026, Tryptamine Therapeutics had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

AU$0

Employees

Market Cap

AU$64.53M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2026	―	―	―
Aug 31, 2024	―	―	―
Jun 30, 2023	―	-618.57K	-100.00%
Jun 30, 2022	618.57K	518.84K	+520.24%
Jun 30, 2021	99.73K	―	+∞%
Jun 30, 2020	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2019	―	―	―
Jun 30, 2018	―	―	―